Brief: Jeune Aesthetics Announces Positive Durability Results For An Investigational Treatment For Improvement Of Fine Lines And Wrinkles

Krystal Biotech

17/11/2022 12:43

Nov 17 (Reuters) - Krystal Biotech Inc  KRYS.O :
    * JEUNE AESTHETICS ANNOUNCES POSITIVE DURABILITY RESULTS FOR
KB301
IN PEARL-1 EXTENSION COHORT, AN INVESTIGATIONAL GENE-BASED
TREATMENT FOR IMPROVEMENT OF FINE LINES AND WRINKLES
    * KRYSTAL BIOTECH-UP TO 9-MONTHS DURABILITY OF EFFECT
OBSERVED IN
PATIENTS AGED 55 TO 76 IN EXTENSION COHORT FOLLOWING
ADMINISTRATION OF HIGH DOSE KB301
    * KRYSTAL BIOTECH INC - CO PLANS ON INITIATING A PHASE 2
TRIAL IN
FINE LINES AND WRINKLES IN 1H 2023
    * KRYSTAL BIOTECH INC - MEAN CHANGE IN SUBJECT SATISFACTION
SCORES
FROM BASELINE RANGED FROM 1.6 TO 1.85 POINTS UP TO NINE MONTHS
AFTER DOSING

Source text for Eikon:  ID:nGNX12zL8y 
Further company coverage:  KRYS.O 
 ((Reuters.Briefs@thomsonreuters.com;))